Long-term postinfarction melatonin administration alters the expression of DHPR, RyR2, SERCA2, and MT2 and elevates the ANP level in the rat left ventricle

Journal of Pineal Research

Volumn 45, Issue 1, 2008, Pages 61-69

  Sallinen, Pirkko ^a   Mänttäri, Satu ^a   Leskinen, Hanna ^a   Vakkuri, Olli ^a   Ruskoaho, Heikki ^a   Saarela, Seppo ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Dihydropyridine receptor; Melatonin; Melatonin receptor; Myocardial infarction; Natriuretic peptides; Ryanodine receptor; Sarco endoplasmic Ca 2+ ATPase2

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; ARALKYLAMINE ACETYLTRANSFERASE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HORMONE ACTION; LONG TERM CARE; MALE; NONHUMAN; OSMOTIC PUMP; PINEAL BODY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNELS, L-TYPE; HEART VENTRICLES; MALE; MELATONIN; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MELATONIN, MT2; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 47249087286     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2008.00556.x     Document Type: Article

References (52)

1. St John Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000 101 : 2981 2988.
2. Holt E, Tonnessen T, Lunde PK et al. Mechanisms of cardiomyocyte dysfunction in heart failure following myocardial infarction in rats. J Mol Cell Cardiol 1998 30 : 1581 1593.
3. Gomez AM, Guatimosim S, Dilly KW et al. Heart failure after myocardial infarction: altered excitation-contraction coupling. Circulation 2001 104 : 688 693.
4. Dhalla NS, Elmoselhi AB, Hata T et al. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 2000 47 : 446 456.
5. Kuroski De Bold ML. Atrial natriuretic factor and brain natriuretic peptide gene expression in the spontaneous hypertensive rat during postnatal development. Am J Hypertens 1998 11 : 1006 1018.
6. Cheng H, Lederer WJ, Cannell MB. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science 1993 262 : 740 744.
7. Barry WH, Bridge JH. Intracellular calcium homeostasis in cardiac myocytes. Circulation 1993 87 : 1806 1815.
8. Bers DM. Cardiac excitation-contraction coupling. Nature 2002 415 : 198 205.
9. 2+ channels in experimental cardiac failure. Am J Physiol 1991 261 : H1979 H1987.
10. 2+/calmodulin-dependent protein kinase is altered in heart failure. Circ Res 2000 86 : 596 605.
11. 2+-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem 1996 164 : 285 290.
12. 2, and SERCA2 after myocardial infarction in the rat left ventricle. Mol Cell Biochem 2007 303 : 97 103.
13. Stangl V, Baumann G, Stangl K et al. Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion. Cardiovasc Res 2002 53 : 12 30.
14. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivates: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
15. Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007 42 : 386 393.
16. Tan DX, Manchester LC, Reiter RJ et al. Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept 2000 9 : 137 159.
17. Reiter RJ, Tan DX, Osuna C, Gitto E. Actions of melatonin in the reduction of oxidative stress: a review. J Biomed Sci 2000 7 : 441 458.
18. 2+]-dependent ATPase in cardiac sarcolemma. J Pineal Res 1993 14 : 178 183.
19. Salie R, Harper I, Cillie C et al. Melatonin protects against ischaemic-reperfusion myocardial damage. J Mol Cell Cardiol 2001 33 : 343 357.
20. Tan DX, Manchester LC, Reiter RJ et al. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J Pineal Res 1998 25 : 184 191.
21. Lagneux C, Joyeux M, Demenge P et al. Protective effects of melatonin against ischemia-reperfusion injury in the isolated rat heart. Life Sci 2000 66 : 503 509.
22. Lochner A, Genade S, Davids A et al. Short- and long-term effects of melatonin on myocardial post-ischemic recovery. J Pineal Res 2006 40 : 56 63.
23. Sallinen P, Mänttäri S, Leskinen H et al. The effect of myocardial infarction on the synthesis, concentration and receptor expression of endogenous melatonin. J Pineal Res 2007 42 : 254 260.
24. Bittner B, Thelly T, Isel H et al. The impact of co-solvents and the composition of experimental formulations on the pump rate of the ALZET osmotic pump. Int J Pharm 2000 205 : 195 198.
25. Prevo M, Johnson P, Chester A. Twenty-eight-day toxicity study of melatonin infused subcutaneously in rats via an osmotic pump. Int J Toxicol 2000 19 : 107 118.
26. Pfeffer MA, Pfeffer JM, Fishbein MC et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979 13 : 293 316.
27. Bradford M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 72 : 248 254.
28. Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970 227 : 680 685.
29. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1976 76 : 4350 4354.
30. Vakkuri O, Leppäluoto J, Vuolteenaho O. Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer. Acta Endocrinol 1984 106 : 152 157.
31. Vakkuri O, Rintamäki H, Leppäluoto J. Presence of immunoreactive melatonin in different tissues of the pigeon (Columba livia). Gen Comp Endocrinol 1985 58 : 69 75.
32. Vuolteenaho O, Koistinen P, Martikkala V et al. Effect of physical exercise in hypobaric conditions on atrial natriuretic peptide secretion. Am J Physiol 1992 263 : R647 R652.
33. Magga J, Marttila M, Mäntymaa P et al. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats. Endocrinology 1994 134 : 2505 2515.
34. Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am J Med 2000 109 : 315 323.
35. Chakraborti S, Das S, Kar P et al. Calcium signaling phenomena in heart diseases: a perspective. Mol Cell Biochem 2007 298 : 1 40.
36. Reiter RJ, Tan DX. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003 58 : 10 19.
37. Hystad ME, Oie E, Grogaard HK et al. Gene expression of natriuretic peptides and their receptors type-A and -C after myocardial infarction in rats. Scand J Clin Lab Invest 2001 61 : 139 150.
38. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003 24 : 341 356.
39. Tamamori M, Ito H, Hiroe M et al. Stimulation of collagen synthesis in rat cardiac fibroblasts by exposure to hypoxic culture conditions and suppression of the effect by natriuretic peptides. Cell Biol Int 1997 21 : 175 180.
40. Horio T, Nishikimi T, Yoshihara F et al. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 2000 35 : 19 24.
41. Tsuruda T, Boerrigter G, Huntley BK et al. Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res 2002 91 : 1127 1134.
42. Magga J, Puhakka M, Hietakorpi S et al. Atrial natriuretic peptide, B-type natriuretic peptide, and serum collagen markers after acute myocardial infarction. J Appl Physiol 2004 96 : 1306 1311.
43. Lee YM, Chen HR, Hsiao G et al. Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res 2002 33 : 72 80.
44. Sahna E, Parlakpinar H, Turkoz Y et al. Protective effects of melatonin on myocardial ischemia-reperfusion induced infarct size and oxidative changes. Physiol Res 2005 54 : 491 495.
45. Szarszoi O, Asemu G, Vanecek J et al. Effects of melatonin on ischemia and reperfusion injury of the rat heart. Cardiovasc Drugs Ther 2001 15 : 251 257.
46. Laine M, Id L, Vuolteenaho O et al. Role of calcium in stretch-induced release and mRNA synthesis of natriuretic peptides in isolated rat atrium. Pflugers Arch 1996 432 : 953 960.
47. 2+ channel activity by human natriuretic peptide in rabbit heart cells. Br J Pharmacol 1995 114 : 1076 1082.
48. Kaneko S, Okumura K, Numaguchi Y et al. Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemic reperfusion injury. Life Sci 2000 67 : 101 112.
49. Chen Z, Chua CC, Gao J et al. Protective effect of melatonin on myocardial infarction. Am J Physiol 2003 284 : H1618 H1624.
50. Tomas-Zapico C, Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005 39 : 99 104.
51. Guerrero JM, Reiter RJ. Melatonin-immune system relationships. Curr Top Med Chem 2002 2 : 167 179.
52. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ et al. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of melatonin as an adjunct in patients with acute myocardial infarction undergoing primary angioplasty: the melatonin adjunct in the acute myocardial infarction treated with angioplasty (MARIA) trial: study design and rationale. Contempor Clin Trials 2007 28 : 532 539.